LOGOLOGOLOGOLOGO
    • About us
      • What we do
      • Who we are
        • Governance
        • Staff
        • Vacancies
    • Members
      • EuropaBio Members
      • About Membership
    • How we work
      • Healthcare Biotechnology Council
        • Patient BioForum
        • Study – Impact of the EU’s General Pharmaceutical Legislation
      • Industrial Biotechnology Council
        • EFIB
        • Microorganisms
      • National Associations Council
      • SME Platform
      • Biomanufacturing Platform
        • Biotechnology in our Lives
    • Activities
      • 25 Years of Innovation
      • The EU Biotech Act
      • European Biotech Week
      • EU Projects
        • PRIMED Project
        • APROVALS Project
    • News & Events
      • News
      • Events
    • Library
    Become a member
    ✕

    A global Europe – the role of transformative legislation: EuropaBio National Associations Council Summit 2023 (Spanish Presidency)

    20/04/2023

    NEWS RELEASE

    Brussels, 20 April 2023 - EuropaBio and its member AseBio, the Spanish Association of Biotechnology Companies, are delighted to invite you to the third National Associations Council (NAC) annual Presidency Summit. Under the title 'A global Europe - the role of transformative legislation', the Summit will be public and held online on June 22, 2023, from 14:00 – 16:00 CET. 

    After over 20 years of technological and scientific advances helping to address unprecedented health and food-security challenges for the Union, Europe is on the verge of revising its general pharmaceutical legislation and presenting its proposal on new genomic techniques for plants - critical policies for European patients, Europe's food security and the green transition.

    Will the new proposal continue to support the healthcare innovation landscape, or will it drive investments outside of Europe and create additional hurdles for patients' timely access to innovative treatments? Will the long-awaited new genomic techniques proposal pave the way for a science-based, future-proof approach to food security and sustainability in Europe, or will Europe resign itself to importing biotechnology innovation?

    National biotechnology associations, invited speakers from industry and policymakers will explore the latest policy proposals and developments and offer their insights into the upcoming work and ambitions of the Council Presidency.

    'The impact of legislation is delivered at the national level for Europe. It is critical that national voices for science, patients, innovation and competitiveness lead the discussion, and we are proud that EuropaBio can deliver this for legislation across sectors,' said Dr Claire Skentelbery, Director General of EuropaBio. 

    Register for the Summit here.

    Highlights from the National Associations Council Summit 2023 here and here. 

    A global Europe - the role of transformative legislation


    Download
    Share
    Communications Team
    Communications Team

    Related posts

    18/05/2026

    Biodefence & Biosecurity in focus for EuropaBio with dedicated Task Force


    Read more
    12/05/2026

    ‘Consistency, cooperation and practicality are the watch words’. EuropaBio reacts to provisional agreement on the Critical Medicines Act


    Read more
    08/05/2026

    Technovative Solutions Ltd. joins EuropaBio: Advancing AI‑Driven and Sustainable Innovation in Biotechnology


    Read more

    Important links

    • Biodefence & Biosecurity in focus for EuropaBio with dedicated Task Force
    • ‘Consistency, cooperation and practicality are the watch words’. EuropaBio reacts to provisional agreement on the Critical Medicines Act

    Categories in our Newsroom

    EBIO-white

    EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

    Contact us

    Extra links

    Members
    Staff
    Privacy policy
    Legal & cookies
    Events
    Newsroom

    Become a member

    Media pack

    © 2026 Europabio. All Rights Reserved. Designed by EYAS
    Become a member

    Vitamin B2

    The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

    Insulin

    Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

    Detergents

    Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

    Clothes

    Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

    Algal Omega 3

    Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

    Cheese

    Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.